In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you have forgotten to take Verezana
If less than 12 hours have passed since you forgot to take only one pill, the contraceptive effect of Verezana is still guaranteed.Resume taking the pills as soon as possible and continue taking the subsequent pills at the usual time.
If more than 12 hours have passed, the contraceptive effect is no longer fully guaranteed.The risk of becoming pregnant is greater if you forget a pill at the beginning or end of the blister.
The risk of becoming pregnant is greater if you forget a pill at the beginning or end of the blister. Therefore, you must follow the following rules.
More than one pill forgotten per blister
Consult your doctor.
Therefore, the procedure to follow in case of forgetting to take pills is as follows:
If you have forgotten to take 1 pill in week 1
Take it as soon as possible, although this means taking two at the same time. Then, continue taking them at the usual time. However, during the 7 days following the pill forgetfulness, an additional barrier contraceptive method (e.g., condom) should be used. If you had sex the week before forgetting the pill, there is a risk of becoming pregnant. In this case, consult your doctor.
If you have forgotten to take 1 pill in week 2
Take it as soon as possible, although this means taking two at the same time. Then, continue taking them at the usual time. If you have taken Verezana regularly for 7 days before forgetting a pill, the contraceptive efficacy is guaranteed, and you do not need to take additional contraceptive measures. If not, or if you forgot to take more than 1 pill, it is recommended to use an additional barrier contraceptive method (e.g., condom) for 7 days.
If you have forgotten to take 1 pill in week 3
Given the proximity of the 7-day break in administration, the contraceptive effect is no longer fully guaranteed. However, contraceptive efficacy is maintained through an adjustment of the administration schedule. If one of the following procedures is followed, then no additional contraceptive measures are necessary, but only if the pill has been taken correctly for 7 days before the first forgetfulness. If not, you should continue according to the point 1 mentioned below. In addition, an additional contraceptive method (e.g., condom) should be used for 7 days.
You can choose between two options:
Take it as soon as possible, although this means taking two at the same time. Then, take the subsequent pills at the usual time. Skip the break and start taking the pills from the next blister directly. It is very likely that no bleeding by deprivation will occur, except if you have consumed the second blister. However, during the intake of the pills from the second blister, bleeding or spotting may occur.
or
You can stop taking the pills from the current blister immediately and start taking the next blister directly after a break of no more than 7 days (the day you forgot the pill must be taken into account!). If you want to start taking the pills from the new blister on the usual day of the week, you can shorten the break.
If you have forgotten one of the pills from the blister and do not have bleeding during the first break without pills, it is possible that you are pregnant. Contact your doctor before starting the next blister.
What to do if you have vomiting or diarrhea?
If you experience vomiting or diarrhea, the active principles of the pill may not have been fully absorbed. Therefore, the effect may be reduced, similar to forgetting a pill. Additional contraceptive measures are necessary. If you vomit within 3-4 hours after taking a pill or have intense diarrhea, take another pill as soon as possible. The new pill should be taken within 12 hours after the usual time. If more than 12 hours have passed, you should follow the advice given in "If you forgot to take Verezana."
If you do not want to change the administration schedule of the pills, you can take the corresponding pill from another blister and continue using this one later as a reserve package.
What to do if you want to delay the bleeding by deprivation?
Although not recommended, you can delay the bleeding by deprivation directly by starting to take the pill from the next Verezana blister without the break. The bleeding by deprivation can be delayed as long as you want, but no longer than until the end of the second blister. During this period, bleeding or spotting may occur. After the regular 7-day break, you can continue taking the pill as usual.
You should consult your doctor before deciding to delay your menstrual period.
What to do if you want to change the day of the week when your menstrual period starts
If you take the pills according to the instructions, you will have your menstrual period approximately every 4 weeks on the same day. If you want to change this day, simply shorten (never lengthen) the interval without pills. If your menstrual period usually starts on a Friday and you want it to start on a Tuesday in the future (3 days earlier), take the first pill from the new blister 3 days earlier than usual. If you make the interval without pills too short (e.g., 3 days or less), it is possible that you will not have any bleeding by deprivation during these days. Then you may experience intermenstrual bleeding.
If you are unsure of what to do, consult your doctor.
If you interrupt the treatment with Verezana
You can stop taking Verezana at any time after consuming a blister. If you do not want to become pregnant, ask your doctor about other reliable contraceptive methods.
If you want to become pregnant, stop taking Verezana and wait for your menstrual period before trying to become pregnant. You will be able to calculate your expected delivery date more easily.
Additional information on special patient groups
Children and adolescents
Verezana can only be used after the first menstrual period (menarche).
Older patients
Verezana can only be used in women before menopause.
Patients with liver insufficiency
Verezana should not be used in women with severe liver disorders (see section 2 "Do not take Verezana").
Patients with renal insufficiency
Verezana has not been studied in women with renal insufficiency. Available data do not suggest any change in treatment for this group of patients.
If you have any other doubts about the use of this medication, consult your doctor.
4. Possible Adverse Effects
Like all medicines, this medicine can cause side effects, although not everyone will experience them. If you experience any side effect, especially if it is severe and persistent, or if you have any health changes that you think may be related to Verezana, consult your doctor.
All women taking combined hormonal contraceptives are at a higher risk of developing blood clots in the veins (venous thromboembolism (VTE)) or blood clots in the arteries (arterial thromboembolism (ATE)). For more detailed information on the different risks of taking combined hormonal contraceptives, see section 2 “What you need to know before starting to use Verezana”.
Severe adverse reactions
Severe reactions associated with the use of the pill are described in section 2 “Warnings and precautions”, where you will find more detailed information.
Immediately contact a doctor if you experience any of the following symptoms of angioedema: swelling of the face, tongue, and/or throat and/or difficulty swallowing or urticaria with possible difficulty breathing (see also section 2 “Warnings and precautions”).
In clinical studies, the following adverse effects were observed with etinilestradiol 0.03 mg and 2 mg of dienogest.
Frequent adverse effects (can affect more than 1 in 10 people):
Headache.
Chest pain, including discomfort and tenderness on palpation.
Less frequent adverse effects (can affect more than 1 in 100 people):
Genital inflammation (vaginitis/vulvovaginitis), fungal infections in the vagina (candidiasis, other vulvovaginal infections).
Increased appetite.
Depressive mood.
Dizziness.
Migraine.
High or low blood pressure; in rare cases, an increase in diastolic blood pressure (lower value of blood pressure).
Abdominal pain (including upper and lower abdominal pain, discomfort/gas).
Nausea, vomiting, or diarrhea.
Acne.
Hair loss (alopecia).
Skin rash (including cutaneous exanthema).
Itching (in some cases throughout the body).
Irregular menstrual bleeding including heavy bleeding (menorrhagia), light bleeding (hypomenorrhea), irregular bleeding (oligomenorrhea), and absence of bleeding (amenorrhea).
Spotting (vaginal bleeding and metrorrhagia).
Menstrual pain (dysmenorrhea), pelvic pain.
Enlargement of the breasts, with swelling, edema.
Vaginal discharge.
Ovarian cysts.
Fatigue, with weakness, tiredness, and general malaise.
Weight gain.
Rare adverse effects (can affect more than 1 in 1,000 people):
Inflammation of the Fallopian tubes or ovaries.
Inflammation of the cervix.
Inflammation of the urinary tract, inflammation of the bladder (cystitis).
Benign proliferation of breast tissue (breast lipoma).
Anemia.
Allergic reactions (hypersensitivity).
Virilization (virilism).
Loss of appetite (anorexia).
Depression, irritability, aggression.
Insomnia, sleep disturbances.
Circulatory disorders in the brain or heart, stroke.
Dystonia (muscle alteration that produces, e.g., an abnormal posture).
Dry or irritated eyes.
Vision disorders.
Sudden hearing loss, alteration of hearing.
Tinnitus.
Vestibular disorders.
Increased heart rate.
Detrimental blood clots in a vein or artery, for example:
In a leg or foot (i.e., DVT).
In a lung (i.e., PE).
Heart attack.
Stroke.
Mild or temporary symptoms similar to a stroke, known as a transient ischemic attack (TIA).
Blood clots in the liver, stomach/intestine, kidneys, or eye.
The chances of having a blood clot may be higher if you have any other condition that increases this risk (see section 2 for more information on conditions that increase the risk of blood clots and symptoms of a blood clot).
Phlebitis (inflammation of the veins).
Varicose veins (varicosis), vein disorders or pain.
Dizziness or fainting when standing up after sitting or lying down (orthostatic hypotension).
Hot flashes.
Inflammation of the gastric mucosa (gastritis), intestinal inflammation (enteritis).
Discomfort in the stomach (dyspepsia).
Reactions/skin disorders, such as allergic reactions, neurodermatitis/atopic dermatitis, eczema, psoriasis.
Intense sweating.
Brownish-yellow patches (called melasma), skin disorders, or increased pigmentation.
Oily skin (seborrhea).
Dandruff.
Excessive hair growth (hirsutism).
Orange skin (cellulitis).
Spider-like nevi (red central spot with radiating reddish extensions, like a spider's web).
Lower back pain, chest pain.
Muscle and bone pain, muscle pain (myalgia), pain in arms and legs.
Cervical dysplasia (abnormal growth of cells on the surface of the cervix).
Pain or cysts in the Fallopian tubes and ovaries.
Cysts in the breasts, benign proliferations in the breasts (fibrocystic breast disease), additional congenital breast glands outside the breast (accessory breasts).
Pain during intercourse.
Nipple discharge.
Menstrual disorders.
Peripheral edema (accumulation of fluid in the body).
Influenza-like illnesses, inflammation, fever.
Increased triglycerides or cholesterol levels in the blood (hypertriglyceridemia, hypercholesterolemia).
Weight loss or fluctuation
Others(frequency not known: cannot be estimated from available data):
Mood changes, increased or decreased libido, incompatibility of contact lenses, urticaria, skin and/or mucous membrane reactions with skin rash, nodules, blistering, or tissue death (erythema nodosum or multiforme), nipple discharge, fluid retention (edema).
Tumors
The incidence of breast cancer diagnosis increases slightly with the use of Verezana. Since breast cancer rarely occurs in women under 40, the risk of developing breast cancer in relation to the general risk is low. For more information, see the section “Verezana and cancer”.
Hepatic tumors (benign and malignant)
Cervical cancer
Other conditions
Women with hypertriglyceridemia (increase in blood fats that increases the risk of pancreatitis when using combined oral contraceptives)
Hypertension
Appearance or worsening of conditions for which the relationship with combined oral contraceptives is not definitive: jaundice and/or itching related to cholestasis (blockage of bile flow), formation of gallstones, a metabolic condition called porphyria, systemic lupus erythematosus (a chronic autoimmune disease), hemolytic-uremic syndrome (a blood clotting disorder), a neurological condition called Sydenham's chorea, gestational herpes (a type of skin condition that occurs during pregnancy), hearing loss related to otosclerosis
Changes in liver function
Alterations in glucose tolerance or effect on peripheral insulin resistance
Crohn's disease, ulcerative colitis
Melasma
Interactions
Unexpected bleeding and/or failure of the contraceptive may result from interactions of other medications with oral contraceptives (e.g., St. John's Wort herbal remedy, medications for epilepsy, tuberculosis, HIV infections, and other infections). See section 2 “Effect of other medications on Verezana
Other severe reactions from taking Verezana, as well as related symptoms, are described in section 2 “Warnings and precautions”.
Reporting of adverse effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
5. Verezana Storage
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the outer packaging and on the blister pack after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 86°F (30°C).
Store the blister pack in the outer packaging to protect it from light.
Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
6. Additional Information
Composition of Verezana
The active principles are dienogest and etinilestradiol. A coated tablet contains 2 mg of dienogest and 0.03 mg of etinilestradiol.
This medication is authorized in the EEA member states with the following names:
Germany:LaViola
Czech Republic:VEREZANA 0.03 mg/2 mg
Spain:Verezana 2 mg/0.03 mg coated tablets EFG
Last review date of this leaflet:July2023
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Информация носит справочный характер и не является медицинской рекомендацией. Перед приёмом любых препаратов проконсультируйтесь с врачом. Oladoctor не несёт ответственности за медицинские решения, принятые на основе этого контента.
Общайтесь с врачом онлайн
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.